Coya Therapeutics, Inc
Price
FilingsNewest: 8-K, Other eventsOct 5 →InsidersNo open-market buys or sales.→HoldersDme 10.0%Vanguard 3.6%Alyeska Investment 3.4%→PeersClosest companies: CMPX, PASG, FATE→
From the filings
Figures
- Revenue
- $8.0Mlast 12 months
- Net income
- −$21.7Mlast 12 months
- Operating cash flow
- −$14.1Mlast 12 months
- Cash and equivalents
- $43.2Mat the last balance sheet
- Shares outstanding
- 23.5M shareson issue